Form 4: Cardinal Health Director Kenny Receives RSU Grant
Insider Transaction Report
Cardinal Health Director Gregory B. Kenny was granted 1,702 restricted share units, vesting in November 2026.
Summary
- Gregory B. Kenny, a Director at Cardinal Health Inc. (CAH), acquired 1,702 common shares through a grant of restricted share units (RSUs).
- The transaction occurred on November 5, 2025, with a price of $0 per share, indicating a grant.
- These restricted share units are scheduled to vest on November 5, 2026, or earlier if the 2026 Annual Meeting of Shareholders takes place before that date.
- Following this grant, Gregory B. Kenny beneficially owns a total of 64,194 common shares.
- A Limited Power of Attorney for SEC reporting purposes, dated May 5, 2025, was also filed, appointing several individuals as attorneys-in-fact for Gregory B. Kenny to handle his SEC filings.
Sentiment
Score: 7
Explanation: The grant of restricted share units to a director is a positive signal of alignment between the board and shareholder interests, though it represents a routine compensation event rather than a significant new development.
Positives
- The grant of restricted share units aligns the director's long-term interests with those of the shareholders.
- Increased beneficial ownership by a director can signal confidence in the company's future performance.
Future Outlook
The restricted share units granted to Director Gregory B. Kenny are scheduled to vest on November 5, 2026, or potentially earlier if the 2026 Annual Meeting of Shareholders occurs before that date.
Industry Context
Granting restricted stock units to directors is a common practice in corporate governance across various industries, including healthcare distribution, to align director incentives with long-term shareholder value.
Comparison to Industry Standards
- The grant of restricted share units to a director is a standard practice in corporate governance, aligning director incentives with shareholder interests.
- Without specific compensation benchmarks for Cardinal Health's peer group (e.g., McKesson, AmerisourceBergen), a direct quantitative comparison of the grant size is not feasible from this filing alone.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Delegation of Authority for SEC Reporting | Gregory B. Kenny executed a Limited Power of Attorney, appointing Jessica L. Mayer, James E. Barnett, Laura C. Dhaliwal, Amanda Pashi, Julie Gilbert, and any duly appointed Corporate Secretary as attorneys-in-fact to handle his SEC filings (Forms 3, 4, 5, and 144) on his behalf. | May 5, 2025 | Streamlines the process for timely and accurate SEC reporting for the director, ensuring compliance with Section 16(a) of the Exchange Act and Rule 144 under the Securities Act. |
Stakeholder Impact
- Shareholders: Increased alignment of director's interests with long-term shareholder value due to equity ownership.
Next Steps
- Vesting of the restricted share units on November 5, 2026, or the date of the 2026 Annual Meeting of Shareholders, whichever is earlier.
Key Dates
| Date | Description |
|---|---|
| May 5, 2025 | Execution date of the Limited Power of Attorney for SEC reporting purposes. |
| November 5, 2025 | Date of transaction for the grant of restricted share units. |
| November 5, 2026 | Scheduled vesting date for the restricted share units (or earlier if the 2026 Annual Meeting of Shareholders occurs before this date). |
| June 23, 2028 | Expiration date of the Notary Public's commission related to the Limited Power of Attorney. |
Recommendation
holdThis Form 4 filing reports a routine grant of restricted share units to a director, which is a standard compensation practice. While it indicates alignment of interests, it does not provide new fundamental information to warrant a change in investment recommendation. The company's overall financial health and strategic outlook, not detailed in this filing, would be the primary drivers for a buy or sell recommendation.
Keywords
Cardinal Health, CAH, Gregory B. Kenny, Director, Form 4, SEC filing, insider transaction, restricted share units, RSU, equity grant, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.